2/2
08:32 am
sprc
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA [Yahoo! Finance]
Low
Report
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA [Yahoo! Finance]
2/2
08:24 am
sprc
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
Low
Report
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
1/26
08:13 am
sprc
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
Medium
Report
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
1/13
07:07 pm
sprc
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity [Yahoo! Finance]
High
Report
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity [Yahoo! Finance]
1/13
06:55 am
sprc
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity
High
Report
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity
1/12
04:02 pm
sprc
SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
High
Report
SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
12/30
08:33 am
sprc
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects [Yahoo! Finance]
Low
Report
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects [Yahoo! Finance]
12/30
08:17 am
sprc
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
Medium
Report
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
12/12
04:30 pm
sprc
IM Cannabis appoints Asi Levi as CFO [Seeking Alpha]
High
Report
IM Cannabis appoints Asi Levi as CFO [Seeking Alpha]
12/2
09:29 am
sprc
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
Medium
Report
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
12/1
08:32 am
sprc
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
High
Report
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
11/26
10:31 am
sprc
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
11/26
08:28 am
sprc
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems [Yahoo! Finance]
High
Report
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems [Yahoo! Finance]
11/26
07:38 am
sprc
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
High
Report
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
11/20
06:42 am
sprc
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
High
Report
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
11/19
07:04 pm
sprc
Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]
Medium
Report
Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression [Yahoo! Finance]